The robotic arm developer has raised series A funding in a round backed by Abacus Alpha and High-Tech Gruenderfonds.

Antibody developer XO1, backed by a Johnson & Johnson-backed fund, has been acquired by another Johnson & Johnson subsidiary, Janssen Parmaceuticals.

US-Russia Innovation Corridor brings Russian edtech startups stateside.

Pfizer-backed Cellectis, which is developing cancer treatments, will issue 3.5 million shares and could raise about $129m.

Tee Pruitt will act as an investment manager at Santander InnoVentures Fund, set up last year to invest along the fintech spectrum.